1 completed, 1 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Terminated 1 |
Follow Stage IV Melanoma: new trials by email Literature Review of Stage IV Melanoma trials Research Report on Stage IV Melanoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Autologous Dendritic Cell-Tumor Cell Immunotherapy for Metastatic Melanoma Autologous Dendritic Cell-Tumor Cell Immunotherapy (DC-TC), Autologous PBMCs in GM-CSF (MC) - Stage IV Melanoma, Stage III Melanoma | Phase 3 | Terminated | Lisata Therapeutics, Inc. | 4 | 2014-10-01 | 2019-05-10 |
| Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma allovectin-7, allovectin-7/dacarbazine, dacarbazine - Stage IV Melanoma, Stage III Melanoma | Phase 3 | Completed | Vical | 1998-07-01 | 2008-07-25 |
Melanoma (2) · Neoplasms (1) · Skin Neoplasms (1)
Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Nerve Tissue (2) · Neuroectodermal Tumors (2) · Neuroendocrine Tumors (2) · Nevi and Melanomas (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Neoplasms (1) · Skin Neoplasms (1)
Allovectin-7 (1) · Dacarbazine (1) · Granulocyte-Macrophage Colony-Stimulating Factor (1)
Lisata Therapeutics, Inc. (1) · Vical (1)
United States (2)
Cherie Smith (1) · Robert O Dillman, MD (1)
2015 (1)